You are here

  • Home
  • Archive
  • Volume 23, Issue 2
  • Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

Article metrics

Article menu
Download PDFPDF
Research methods and reporting
Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 201801812
Mar 201804124
Apr 201804220
May 201803215
Jun 2018075
Jul 2018033
Aug 20180135
Sep 201801810
Oct 20180175
Nov 2018062
Dec 2018033
Jan 20190132
Feb 2019052
Mar 20190124
Apr 2019021
May 2019054
Jun 2019053
Jul 2019033
Aug 2019053
Sep 2019001
Oct 2019013
Nov 2019044
Dec 2019011
Jan 2020022
Feb 2020010
Mar 2020011
Apr 2020011
May 2020013
Jun 2020003
Jul 2020044
Aug 2020012
Sep 2020021
Oct 2020010
Nov 2020011
Dec 2020011
Jan 2021011
Feb 2021035
Mar 2021023
Apr 2021012
May 2021014
Jun 2021011
Jul 2021001
Aug 2021012
Oct 2021012
Dec 2021012
Jan 2022010
Mar 2022001
May 2022021
Jun 2022088
Aug 2022011
Sep 2022001
Nov 2022033
Dec 2022032
Jan 2023021
Jun 2023011
Aug 2023001
Sep 2023021
Nov 2023010
Dec 2023034
Jan 2024011
Mar 2024010
Total0313203